Completed NA INTERVENTIONAL 1-arm NCT03988244

HeartLight X3 Endoscopic Ablation System With Excalibur Balloon for Treatment of Symptomatic Persistent AF

Clinical Study of the HeartLight X3 Endoscopic Ablation System (EAS) With Excalibur Balloon Compared to HeartLight System in the Treatment of Symptomatic Persistent Atrial Fibrillation

Sponsor: CardioFocus

Conditions Atrial Fibrillation

Interventions HeartLight X3

Updated 5 times since 2019 Last updated: Jul 19, 2021 Started: Feb 26, 2019 Primary completion: Apr 30, 2019 Completion: Apr 3, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03988244, this NA trial focuses on Atrial Fibrillation and remains completed. Sponsored by CardioFocus, it has been updated 5 times since 2019, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Sep 2021 — Jul 2024 [monthly]

Completed NA

Status: Active Not Recruiting → Completed
Jan 2021 — Sep 2021 [monthly]

Active Not Recruiting NA
Jul 2019 — Jan 2021 [monthly]

Active Not Recruiting NA

First recorded

Feb 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

CardioFocus

Data source: CardioFocus

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Prague, Czechia